News
Kalydeco is used to treat cystic fibrosis in patients aged six years and above who have the G551D mutation in their gene for the protein called cystic fibrosis transmembrane conductance regulator (... Weiterlesen
Yervoy (ipilimumab) is the first drug ever shown to help late-stage melanoma patients live longer. However, it does not cure the disease.
"Late-stage melanoma is devastating, with very few treatment... Weiterlesen
BRUSSELS, Sept. 20, 2012 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced the launch of Plenadren® (hydrocortisone modified-release tablet) in Denmark, the first country in the... Weiterlesen
XALKORI® (crizotinib) is a prescription medicine used to treat non-small cell lung cancer (NSCLC) that is advanced or has spread to other parts of the body and is caused by a defect in a gene called... Weiterlesen
TARRYTOWN, N.Y., Nov. 27, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the... Weiterlesen
On October 26, 2009, the U.S. Food and Drug Administration granted accelerated approval to ofatumumab (Arzerra™, GlaxoSmithKline) for the treatment of patients with chronic lymphocytic leukemia (CLL... Weiterlesen
Basel, 21 November 2008
Roche today announced that the European Committee on Human Medicinal Products (CHMP) has given a positive recommendation for RoActemra (tocilizumab, known as Actemra outside... Weiterlesen
LITAK® (cladribine, 2-chloro-2'-deoxyadenosine, 2-CdA) is a purine nucleoside.
LITAK® is approved for recurrent or refractory follicular and diffuse non-Hodgkin's lymphoma, recurrent or refractory... Weiterlesen
1. Si vous ne possédez pas déjà un compte, demandez-le par le lien approprié. Un administrateur va vous activer l'accès.
[IMMAGINE1]
2. Connectez-vous avec le nom d'utilisateur et le mot de... Weiterlesen
Unipharma foi confirmado como o distribuidor exclusivo para a Itália e Vidaza Talidomida Pharmion.